US 2013/0156738 A1Published application

Bifidobacterium adolescentis spm0212 having antiviral activity for hepatitis b virus, and pharmaceutical composition for preventing and treating hepatitis b comprising thereof

AssigneeSahmyook University

InventorsNam Joo HA, Kang Oh LEE, Do Kyung Lee

Life of this patent

Estimating the term…

Loading patent…

Abstract

The present invention relates to a bifidobacterium adolescentis SPMO212 having antiviral activity for hepatitis B virus, and a pharmaceutical composition for preventing and treating hepatitis B comprising thereof. The bifidobacterium adolescentis SPMO212 or its fraction of the present invention shows antiviral activity for hepatitis B virus by blocking the production of antigen s of hepatitis B virus, and by inhibiting the expression of DNA, RNA and HBsAg of the HBV.

Claims10

Dependent claims

An isolated bifidobacterium adolescentis SPMO212 (Accession No.:

KCTC 18120P) showing having antiviral activity for hepatitis B virus.

Dependencies are inferred from the claim text.

Facts

Application: 13/336,159Filed 23 Dec 2011
Priority: KR 10-2011-013676016 Dec 2011
Published: 20 Jun 2013
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

A61K 35/745
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs: bifidobacteria
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 31/20
Antivirals: for DNA viruses

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key